IP Library Patent Application 16041282
Patent Application
App. No. 16/041,282

METHODS FOR PREPARING OLTIPRAZ

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/041,282
Abstract

The invention provides improved methods of synthesizing oltipraz, which result in higher overall yield and better purity of the desired product.

Claims (16)

1 - 20 . (canceled)

21 . A method of making oltipraz, comprising the steps of:

(i) reacting a quantity of pyrazine-2-carboxylic acid methyl ester with methyl propionate to form methyl 2-methyl-3-oxo-3-(pyrazin-2-yl)propanoate, wherein the reaction is carried out in the presence of a base comprising potassium t-butoxide or sodium pentanoate, and a solvent comprising 1,4-dioxane in tetrahydrofuran (THF), wherein the ratio of 1,4-dioxane in the THF is at least about 1:5;

(ii) adding at least one aqueous liquid to quench the reaction in Step (i);

(iii) adding a nonpolar organic solvent and an ionic salt, thereby forming composition comprising an aqueous component and an organic component, wherein the organic component comprises the nonpolar solvent and methyl 2-methyl-3-oxo-3-(pyrazin-2-yl)propanoate;

(iv) separating the organic component from the aqueous component;

(v) reacting the methyl 2-methyl-3-oxo-3-(pyrazin-2-yl)propanoate ester in the organic component with P 2 S 5 in the presence of a nonpolar organic solvent to form 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione (oltipraz).

22 . The method of claim 21 , wherein the ratio of 1,4-dioxane to THF in Step (i) is from about 1:5 to about 1:3.

23 . The method of claim 22 , wherein, and the ratio of 1,4-dioxane to THF is about 4:1.

24 . The method of claim 21 , wherein the base comprises potassium t-butoxide.

25 . The method of claim 21 , wherein the mole ratio of the base to methyl propionate is from about 3:1 to about 1:1.

26 . The method of claim 21 , wherein the nonpolar organic solvent used in Step (iii) comprises toluene.

27 . The method of claim 21 , wherein the nonpolar organic solvent in Step (v) comprises toluene.

28 . The method of claim 21 , wherein the nonpolar solvent in Step (iii) is the same nonpolar solvent used in Step (v).

29 . The method of claim 21 , wherein the yield of oltipraz is greater than 20% based on the amount of pyrazine-2-carboxylic acid methyl ester.

30 . The method of claim 29 , wherein the oltipraz obtained from Step (v) is subjected to recrystallization to yield oltipraz having a purity of at least 97%.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2025
From: ZPNE GROUP GMBH
To: SUPPORTIVE THERAPEUTICS AG
Reel/Frame 071622/0178 →
MERGER BY ACQUISITION Recorded Jul 3, 2025
From: ST IP HOLDING AG
To: ZPNE GROUP GMBH
Reel/Frame 071925/0865 →
LIEN Recorded Jun 17, 2022
From: ST IP HOLDING AG
To: FOLEY HOAG LLP
Reel/Frame 060520/0681 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2018
From: FRAMROZE, BOMI P.
To: ST IP HOLDING AG
Reel/Frame 046784/0719 →